Qnova Lifesciences
QNova LifeSciences is a private, founder-led FDA regulatory consulting CRO that guides drug and medical device developers through approval, clinical, and commercialization pathways. It serves early-stage startups, foreign companies entering the US, and academic spinouts, anchored by its annual JPM Healthcare Week Partnering Forum.
- Company typePrivate
- Founded2014
- HeadquartersColumbia, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Qnova Lifesciences does
QNova LifeSciences (legal entity LifeSciences Regulatory Solutions, LLC) is a private, founder-led global regulatory consulting and contract research organization (CRO) headquartered at the Maryland Innovation Center in Columbia, MD, with a second office in San Francisco. Founded in 2014 and rebranded from CSSi LifeSciences to QNova LifeSciences in January 2025, the firm specializes in guiding therapeutic and medical device developers through FDA approval pathways, with a documented track record of 85+ NDA/ANDA/CVM/BLA submissions, 200+ medical device approvals, and experience across 500+ drugs/biologics spanning 150+ indications and 30+ therapeutic areas.
The company's core offering is organized around four service lines: Regulatory Solutions (drug and medical device pathway strategy, medical writing, quality management systems including QMSR compliance), Clinical Services (Phase I through commercialization, with connections to 700+ clinical sites), Commercialization Solutions (US market entry and investor readiness), and Strategy & Project Management. Adjacent programs include the QNova Accelerator ($6,000, 12-month fee-based program with no equity taken) and QNova Capital (investment and funding support). The firm owns and operates the annual Partnering Forum held during J.P. Morgan Healthcare Week in San Francisco, which in 2026 attracted 1,400+ in-person participants from 600+ companies across 25 countries.
QNova generates revenue primarily through fee-for-service regulatory consulting engagements, the QNova Accelerator program fees, and tiered sponsorships for its annual Partnering Forum. Pricing for consulting is quote-based and not publicly disclosed. Its customer base spans early-stage life science startups, foreign companies entering the US market (notably Korea, Japan, and Europe), university and federal laboratory spinouts, and physician-entrepreneurs. Strategic alliances include Medical Technology Enterprise Consortium (MTEC), Liberi Group (exclusive consultancy), Phase Advance (AI-driven non-animal drug development), Biotoxtech (Korean non-clinical CRO), Tonic Bioventures (venture fund), Trifermed, and Jaunt.
Qnova Lifesciences firmographics
Firmographics- Name
- Qnova Lifesciences
- Legal name
- LifeSciences Regulatory Solutions, LLC
- Website
- https://qnovals.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- QNova LifeSciences is a private, founder-led FDA regulatory consulting CRO that guides drug and medical device developers through approval, clinical, and commercialization pathways. It serves early-stage startups, foreign companies entering the US, and academic spinouts, anchored by its annual JPM Healthcare Week Partnering Forum.
- Ownership category
- akta.pro rank
Qnova Lifesciences industry classification
Industry- Product category
- Pharmaceutical Regulatory Consulting
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Quality Management Systems (QMS) & GxP Documentation (HLAGAKAD)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Qnova Lifesciences is headquartered
LocationHeadquarters
- HQ city
- Columbia
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Qnova Lifesciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Regulatory Consulting Services: Fee-for-service regulatory consulting engagements providing strategic guidance on FDA approval pathways for drugs and medical devices, including submission services, quality management systems, and clinical development support
- QNova Accelerator Program: 12-month fee-based accelerator program at $6,000 providing regulatory, commercialization, and investor-readiness support to early-stage life science companies
- Partnering Forum Sponsorships: Sponsorship packages for annual Partnering Forum during J.P. Morgan Healthcare Week, with tiered benefits including virtual platform access, logo placement, and speaking opportunities
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | QNova Accelerator 12-Month Program |
| Other | Annual | Partnering Forum Sponsorship Packages |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Qnova Lifesciences product offering
Product offeringCore offering
Qnova Lifesciences provides regulatory consulting, clinical trial management, and commercialization services for medical device and therapeutic companies seeking FDA approval and U.S. market entry. The firm supports early-stage and international life sciences companies with strategy, clinical services, and non-dilutive funding guidance to bring products from concept to market.
Product overview
QNova Lifesciences is a global Contract Research Organization (CRO) and consulting group offering an integrated portfolio of regulatory, clinical, and commercialization services for drugs and medical devices. The core offering consists of Regulatory Solutions (covering drug development, medical devices, medical writing, and quality management systems), Clinical Services (Phase I through commercialization), Commercialization Solutions (U.S. market entry and investor readiness), and Strategy & Project Management. The company also offers complementary programs including the QNova Accelerator (12-month fee-based support without equity), QNova Capital, and the Annual Partnering Forum during J.P. Morgan Healthcare Week. The integrated model combines regulatory expertise with commercialization guidance to help life science companies navigate FDA approval and market entry.
Differentiator
Problem solved
Functional benefit
Products and services
- Regulatory Solutions
- Clinical Services
- Commercialization Solutions
- Strategy and Project Management
- QNova Accelerator
- Annual Partnering Forum
Quantifiable outcome
- 85+ FDA NDA, ANDA, CVM and BLA submissions
- +4 more outcomes
Companies that use Qnova Lifesciences
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Qnova Lifesciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Qnova Lifesciences partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, major and minor.
- Medical Technology Enterprise Consortium (MTEC)coreMTEC is a 501(c)(3) biomedical technology consortium collaborating with US government agencies under a 10-year renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command. MTEC co-hosts the annual QNova LifeSciences Partnering Forum during JPM Healthcare Week, focusing on medical solutions development for military personnel and civilians.
- Liberi GroupcoreLiberi Group is a platinum sponsor and strategic partner providing strategic consultancy services. De Jong of Liberi Group led sessions at QNova's Partnering Forum on biotech partnership pitfalls.
- Phase AdvancemajorPhase Advance partnered with QNova Capital to forge an alliance ushering in AI-driven, non-animal drug development era, combining AI capabilities with regulatory expertise.
- BesselmajorBessel is a platinum sponsor and co-host of the Build for Impact Startup Showcase during J.P. Morgan Healthcare Week, held at the QNova Partnering Forum.
- OrganTech Inc.majorOrganTech Inc. partnered with QNova LifeSciences for FDA application of next-generation bio-implant technology, leveraging QNova's regulatory expertise.
- Liberi GroupcoreQNova LifeSciences and Liberi Group entered an exclusive consultancy agreement to provide joint services to clients requiring strategic partnership and business development guidance.
- TrifermedmajorPartnership to accelerate global healthcare innovation access into the US market, combining Trifermed's international network with QNova's US regulatory expertise.
- JauntminorPartnership with market strategy leader Jaunt to provide market entry and strategy services to medtech innovators entering the US healthcare market.
- BiotoxtechmajorBiotoxtech is Korea's No. 1 non-clinical CRO with GLP qualification from US FDA, conducting 2,000+ non-clinical studies annually. Partnership provides non-clinical trial and consulting services to facilitate FDA approval for Korean and foreign biotech companies.
- Tonic BioventurescoreTonic bioventures partnered with CSSi LifeSciences (now QNova) to form a new life science venture fund that will invest in breakthrough medical technologies, leveraging regulatory and early clinical expertise through QNova for portfolio companies. Fund plans to source 12-16 investments over 3-5 years.
- ITOCHU InternationalminorSenior Manager Shohei Shibata discussed Japanese long-term strategic capital alignment with US life sciences innovation at QNova's Partnering Forum.
- Excellere PartnersminorEric Matson of Excellere Partners spoke at QNova's Partnering Forum on life sciences fundraising insights and market volatility.
- StifelminorStifel released its 2026 biopharma market outlook presented at QNova Life Sciences, highlighting a shift toward disciplined early-stage investing.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Qnova Lifesciences competitors and assessment
Company assessmentBroad incumbents
- Parexel: Large global CRO with full-service clinical, regulatory, and commercialization offerings. Overlaps with QNova on FDA regulatory strategy and clinical trial services, but operates at materially larger scale across pharma and biopharma.
- Medpace: Mid-to-large global CRO focused on clinical development for emerging biopharma. Comparable to QNova in serving small and mid-sized sponsors, but with much larger clinical operations and global delivery model.
- IQVIA: Largest global CRO and life sciences services platform with deep regulatory, clinical, and real-world evidence capabilities. Overlaps with QNova across FDA strategy and submissions, but at far greater scale and with proprietary technology platforms.
- ICON plc: Major global CRO providing clinical, regulatory, and laboratory services. Comparable on regulatory affairs and clinical development services, but serves enterprise pharma with much broader operational footprint than QNova.
- Charles River Laboratories: Major CRO spanning preclinical, clinical, and manufacturing services. Comparable to QNova's clinical services and FDA strategy offerings, though with much broader preclinical and CDMO capabilities.
- Worldwide Clinical Trials: Mid-size global CRO providing clinical and post-approval services. Overlaps with QNova on clinical trial execution and regulatory strategy, particularly for mid-sized pharma and biotech sponsors.
Direct peers
- PharmaLex: Regulatory affairs, quality, and pharmacovigilance consulting CRO. Directly comparable service mix to QNova across regulatory submissions, GxP compliance, and clinical development for both pharma and medical device sponsors.
- Camargo Pharmaceutical Services: Specialized regulatory strategy and drug development consulting firm. Comparable in its focus on 505(b)(2), ANDA, and NDA pathway planning plus clinical and CMC support for small and mid-sized life sciences companies.
- Clinipace Worldwide: Mid-size CRO focused on emerging biopharma and medical device sponsors with adaptive clinical and regulatory services. Highly comparable to QNova in serving small and mid-sized life sciences companies seeking integrated regulatory and clinical support.
- ProPharma Group: Global regulatory, compliance, and quality consulting firm serving pharma, biotech, and medical device companies. Highly comparable to QNova as a fee-for-service regulatory consultancy covering FDA submissions, QMS, and clinical compliance across therapeutic and device portfolios.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Qnova Lifesciences social profiles
Digital presenceQnova Lifesciences compliance and trust
Trust signalCompliance4 records
Qnova Lifesciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qnova Lifesciences leadership team
Management profileNumber of profiles
Profiles2 records
Qnova Lifesciences subsidiaries and ownership
Company hierarchySubsidiaries2 records
Qnova Lifesciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qnova Lifesciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qnova Lifesciences
What does Qnova Lifesciences do?
Qnova Lifesciences provides regulatory consulting, clinical trial management, and commercialization services for medical device and therapeutic companies seeking FDA approval and U.S. market entry. The firm supports early-stage and international life sciences companies with strategy, clinical services, and non-dilutive funding guidance to bring products from concept to market.
Is Qnova Lifesciences a public or private company?
Qnova Lifesciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Qnova Lifesciences founded?
Qnova Lifesciences was founded in 2014. It employs 11 to 50 people.
Where is Qnova Lifesciences based?
Qnova Lifesciences is headquartered in Columbia, United States, in the North America region.
How does Qnova Lifesciences make money?
Three revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are QNova Accelerator Program and partnering Forum Sponsorships.
Who are Qnova Lifesciences's main competitors?
Broad incumbents on record are Parexel, Medpace, IQVIA, ICON plc, Charles River Laboratories and Worldwide Clinical Trials. Direct peers are PharmaLex, Camargo Pharmaceutical Services, Clinipace Worldwide and ProPharma Group.
Does Qnova Lifesciences have an API?
No public API is recorded for Qnova Lifesciences.
What industry is Qnova Lifesciences in?
Qnova Lifesciences's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAD, Quality Management Systems (QMS) & GxP Documentation, with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5417 and its SIC code is 8731.